Article
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.
The Prostate - 1 Feb 2000
Spiotto M T, Chung T D
Abstract excerpt
BACKGROUND: In prostate cancer, we and others have observed distinct phenotypic responses to interleukin-6 (IL-6), which acts either as a paracrine growth inhibitor in the LNCaP cell line or as an autocrine growth stimulator in PC-3, DU145, and TSU cell lines. To understand the underlying mechani...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
